Qiagen Discloses It Spent up to $181.7M on Recent Acquisitions

May 09, 2012

|

NEW YORK (GenomeWeb News) – Qiagen made three acquisitions in April and May for up to $181.7 million, it disclosed in a document filed yesterday with the US Securities and Exchange Commission.

In its Form 10-Q Qiagen said that the acquisitions included the remaining 60 percent of Scandinavian Gene Synthesis that it didn't already own, and AmniSure International. Qiagen did not provide details on its third acquisition.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Helix Launches 'App Store'

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

More CAR-T Therapies Sought

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Telomeres of Spawning Salmon

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

This Week in PLOS

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.

Main menu